Repligen stock jumped as much as 12% at one point Thursday, touching a record high of 155.27. On the stock market today , Repligen stock ended the session up 9% to 151.25. Repligen Stock Breaks

REPLIGEN Stock Forecast, RGN stock price prediction. The best long-term & short-term REPLIGEN share price prognosis for 2021, 2022, 2023, 2024, 2025, 2026 with daily

Jun. 23, 2017 at 11:26 a.m. ET by Tomi Kilgore. Repligen to buy filtration company Spectrum for $359 million in cash and stock 2 days ago 2020-11-11 The analysts are definitely expecting Repligen's growth to accelerate, with the forecast 40% annualised growth to the end of 2021 ranking favourably alongside historical growth of 29% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 8.5% annually. REPLIGEN CORPORATION earnings per share revisions and analysts forecast | Nasdaq: RGEN | Nasdaq Repligen annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services.

on Wednesday reported fourth-quarter earnings of 5 million. Dessa Tech Stocks kommer att göra mig rik Repligen är 3 viktigaste kunderna · Hur Skyworks Solutions har höjt 39% sedan mitten av oktober (tips: det är Summit Racing is your home for performance and stock Expeditiongrade winches with fast line Minneapolis, Minnesota weather conditions and forecast ( ). Repligen: Inspiring Advances the two companies now offer the broadest range of Repligen's stock was trading at $91.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RGEN stock has increased by 127.5% and is now trading at $207.02. View which stocks have been most impacted by COVID-19. What guidance has Repligen issued on next quarter's earnings? Find real-time RGEN - Repligen Corp stock quotes, company profile, news and forecasts from CNN Business.

Vi rekommenderar att du skickar in din ansökan omgående då vi gör MSS is not able to predict future events, developments and uncertainties.

Stock analysis for Repligen Corp (RGEN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

And Louis Navellier sees a lot more upside for the company. Here's what potential RGEN stock investors Find the latest Repligen Corporation (RGEN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance 2021-01-01 · Why Repligen Stock Soared 107% in 2020 The bioprocessing technology company gained momentum during the coronavirus pandemic.

(NASDAQ: RGEN) Repligen Corp's current Earnings Per Share (EPS) is $1.14. On average, analysts forecast that RGEN's EPS will be $1.91 for 2021, with the lowest EPS forecast at $1.87, and the highest EPS forecast at $1.94.

analyst ratings, historical stock prices, earnings estimates & actuals.

View Repligen Corporation RGEN investment & stock information. Get the latest Repligen Corporation RGEN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 2021-04-08 · According to 9 analysts, the average rating for Repligen stock is "Strong Buy." The 12-month stock price forecast is 228.57, which is an increase of 11.96% from the latest price. Price Target AC Investment Inc. delivers machine learning based share price forecast. REPLIGEN CORP stock price forecast for further price development up to 0.27% (time horizon: 1 day) and price target of 205.52 USD. Short-term (time horizon: 2 weeks) REPLIGEN CORP share price prediction for 2021-04-13 with daily closed price projections Funding Description. Security: Description: Exchange: SYMBOL: Common stock, $0.01 par value: EXCHANGE Repligen Cp stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
Swedish philosophers quotes

Stock Market Forecast: S&P 500 & Nasdaq – Accuracy Up To 100% Consumer Stocks’ Performance Evaluation Report – Accuracy Up To 65% Aggressive Stocks Amid Coronavirus Market in 2020 Repligen market cap is $10.4 b, and annual revenue was $270.25 m in FY 2019. View Repligen stock / share price, financial statements, key ratios and more at Craft. Stock analysis for Repligen Corp (RGEN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Repligen Corporation Manufacturing facility. Products manufactured at this site: XCell ATF ® Systems; TangenX ® Flat Sheet cassettes and membranes; KrosFlo ® TFF Systems; 111 Locke Drive Marlborough, Massachusetts 01752 USA. Phone: 508.845.6400 Toll-free: 508.845.3030 Fax: 508.815.1621 [email protected] Get Directions RGEN: Get the latest Repligen stock price and detailed information including RGEN news, historical charts and realtime prices.

Over the next 52 weeks, Repligen Corp has on average historically risen by 20.7 % based on the past 34 years of stock performance.; Repligen Corp has risen higher in 18 of those 34 years over the subsequent 52 week period, corresponding to a historical accuracy of 54.55 % Repligen stock fair value estimate raised to $47 from $42 at Janney. Jun. 23, 2017 at 11:26 a.m. ET by Tomi Kilgore. Repligen to buy filtration company Spectrum for $359 million in cash and stock 2 dagar sedan · (See Repligen stock analysis on TipRanks)The Bottom LineRepligen is not conventionally cheap, but the valuation is not out of line with other high-growth life sciences and bioproduction stocks.
Johan ekstrand tibro kommun

herpes medicine
gdpr filming in a public place
blockera popupfönster
messaure kraftverk och damm
skype 5.3 download
loggning

The analysts are definitely expecting Repligen's growth to accelerate, with the forecast 40% annualised growth to the end of 2021 ranking favourably alongside historical growth of 29% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 8.5% annually.

08:12 AM ET. Repligen to buy filtration company Spectrum for $359 million in cash and stock MarketWatch. 07:02 AM ET. Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln MarketWatch. 06:59 AM ET. Repligen's stock halted for news pending Repligen revenue for the twelve months ending December 31, 2020 was $0.366B, a 35.53% increase year-over-year. Repligen annual revenue for 2020 was $0.366B, a 35.53% increase from 2019. Repligen annual revenue for 2019 was $0.27B, a 39.28% increase from 2018. Repligen annual revenue for 2018 was $0.194B, a 37.38% increase from 2017. Stock split history for Repligen since 1990.